Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000300
Chunk: 57

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 57
---
ys previously borrowed and then outstanding, notwithstanding that the same may result in the said limit          
 being exceeded during such period.                                                                                                              |

| 42 |

| 89.3 | In this Article: |

| (A) | share capital allotted shall be treated as issued and any share capital already called up or payable at                                
 any future date within the following twelve months shall be treated as already paid up and if the Company proposes to issue any shares 
 for cash and the issue of such shares has been underwritten then such shares shall be deemed to have been issued and the subscription  
 moneys (including any premium) payable in respect thereof within the following twelve months shall be deemed to have been paid up;     |

| (B) | any company which it is proposed shall become a subsidiary contemporaneously with any relevant transaction 
 shall be treated as if it had already become a subsidiary;                                                 |

| (C) | the following shall (unless otherwise taken into account) be deemed to be included in moneys borrowed                                     
 (a) debentures issued in whole or in part for a consideration other than cash, (b) amounts outstanding under acceptance credits (other    
 than in respect of the purchase of goods in the ordinary course of trading), (c) the nominal amount of any share capital issued and the   
 principal amount of any moneys borrowed the redemption or repayment, whereof is guaranteed by the Company or by any subsidiary except     
 in so far as such share capital is for the time being held by or such moneys are for the time being owing to, and the beneficial interest 
 therein is vested in, the Company or any subsidiary; and                                                                                  |

| (D) | any fixed premium payable on final redemption or repayment of any debentures or other borrowed moneys   
 or share capital shall be taken into account as an addition to the principal or nominal amount thereof. |

| 89.4 | No person dealing with the Company or any of its subsidiaries shall by reason of the foregoing provision                                
 be concerned to see or inquire whether the said limit is observed and no debt incurred or security given in excess of such limit shall  
 be invalid or ineffectual unless the lender or the recipient of the security had at the time when the debt was incurred or the security 
 given express notice that the said limit had been or would thereby be exceeded.                                                         |

<div align='center'>DIRECTORS’ REMUNERATION, EXPENSES AND
BENEFITS</div>

| 90 | FEES